Effective May 17, 2013, IBC's medical policy on artificial intervertebral disc insertion will be updated to include artificial intervertebral disc insertion in the cervical spine when medically necessary as an alternative surgical treatment to preserve range of motion for a select population.

Previously, artificial intervertebral disc insertion in the cervical spine was considered experimental and investigational. However, based on the current available peer-reviewed literature and clinical input, artificial intervertebral disc insertion in the cervical spine will now be considered medically necessary in a select population.

About artificial intervertebral disc insertion

Artificial intervertebral disc insertion is a technology intended for use in the cervical or lumbar spine to treat degenerative disc disease (DDD). DDD is a common cause of neck and/or low back pain. Spinal fusion is considered the established treatment for DDD for the resolution of pain and neurologic symptoms. However, artificial intervertebral disc insertion has been proposed as an alternative surgical treatment.

The current evidence suggests that in a select population, artificial intervertebral disc insertion in the cervical spine may offer lower re-operation rates and preserve range of motion. Additionally, mid-term results suggest that cervical artificial intervertebral disc insertion is not inferior to spinal fusion.

The available peer-reviewed literature and clinical input suggests that the current evidence for artificial intervertebral disc insertion in the lumbar spine remains limited and insufficient to permit conclusions regarding long-term safety and effectiveness. Therefore, artificial intervertebral disc insertion in the lumbar spine remains experimental and investigational.

Visit the Medical Policy Portal after May 17, 2013, to review the revised Medical Policy #11.14.19g: Artificial Intervertebral Disc Insertion in its entirety.